Migration of Durasphere after Transurethral Injection for Stress Urinary Incontinence

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Stress urinary incontinence in women can be treated by injectable bulking agents. Durasphere is promoted as a nonantigenic, noncarcinogenic and nonmigratory substance. Case History: A 67-year-old-woman underwent multiple treatments for stress urinary incontinence, including 2 periurethral injections of Durasphere. Several months later, a voiding cystogram, ordered to assess her persistent incontinence, revealed Durasphere beads on each side of the urethra as well as in the adjacent lymphatic channels. Conclusion: This case report underlines the potential hazard of particle migration with this agent.

Original languageEnglish (US)
Pages (from-to)39-40
Number of pages2
JournalJournal of Pelvic Medicine and Surgery
Volume10
Issue number1
DOIs
StatePublished - 2004

Fingerprint

Stress Urinary Incontinence
Injections
Urethra
durasphere
Therapeutics

Keywords

  • Bulking agent
  • Durasphere
  • Migration
  • Urinary incontinence

ASJC Scopus subject areas

  • Surgery

Cite this

Migration of Durasphere after Transurethral Injection for Stress Urinary Incontinence. / Vidart, A.; Zimmern, Philippe E.

In: Journal of Pelvic Medicine and Surgery, Vol. 10, No. 1, 2004, p. 39-40.

Research output: Contribution to journalArticle

@article{d7171a816744430694d69278276a1989,
title = "Migration of Durasphere after Transurethral Injection for Stress Urinary Incontinence",
abstract = "Background: Stress urinary incontinence in women can be treated by injectable bulking agents. Durasphere is promoted as a nonantigenic, noncarcinogenic and nonmigratory substance. Case History: A 67-year-old-woman underwent multiple treatments for stress urinary incontinence, including 2 periurethral injections of Durasphere. Several months later, a voiding cystogram, ordered to assess her persistent incontinence, revealed Durasphere beads on each side of the urethra as well as in the adjacent lymphatic channels. Conclusion: This case report underlines the potential hazard of particle migration with this agent.",
keywords = "Bulking agent, Durasphere, Migration, Urinary incontinence",
author = "A. Vidart and Zimmern, {Philippe E.}",
year = "2004",
doi = "10.1097/01.spv.0000119194.82441.a4",
language = "English (US)",
volume = "10",
pages = "39--40",
journal = "Female Pelvic Medicine and Reconstructive Surgery",
issn = "2151-8378",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Migration of Durasphere after Transurethral Injection for Stress Urinary Incontinence

AU - Vidart, A.

AU - Zimmern, Philippe E.

PY - 2004

Y1 - 2004

N2 - Background: Stress urinary incontinence in women can be treated by injectable bulking agents. Durasphere is promoted as a nonantigenic, noncarcinogenic and nonmigratory substance. Case History: A 67-year-old-woman underwent multiple treatments for stress urinary incontinence, including 2 periurethral injections of Durasphere. Several months later, a voiding cystogram, ordered to assess her persistent incontinence, revealed Durasphere beads on each side of the urethra as well as in the adjacent lymphatic channels. Conclusion: This case report underlines the potential hazard of particle migration with this agent.

AB - Background: Stress urinary incontinence in women can be treated by injectable bulking agents. Durasphere is promoted as a nonantigenic, noncarcinogenic and nonmigratory substance. Case History: A 67-year-old-woman underwent multiple treatments for stress urinary incontinence, including 2 periurethral injections of Durasphere. Several months later, a voiding cystogram, ordered to assess her persistent incontinence, revealed Durasphere beads on each side of the urethra as well as in the adjacent lymphatic channels. Conclusion: This case report underlines the potential hazard of particle migration with this agent.

KW - Bulking agent

KW - Durasphere

KW - Migration

KW - Urinary incontinence

UR - http://www.scopus.com/inward/record.url?scp=1642290058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642290058&partnerID=8YFLogxK

U2 - 10.1097/01.spv.0000119194.82441.a4

DO - 10.1097/01.spv.0000119194.82441.a4

M3 - Article

AN - SCOPUS:1642290058

VL - 10

SP - 39

EP - 40

JO - Female Pelvic Medicine and Reconstructive Surgery

JF - Female Pelvic Medicine and Reconstructive Surgery

SN - 2151-8378

IS - 1

ER -